452 filings
Page 9 of 23
6-K
CLLS
Cellectis
5 Aug 21
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
5 Aug 21
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
4:32pm
6-K
CLLS
Cellectis
14 Jun 21
Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities
4:30pm
6-K
CLLS
Cellectis
2 Jun 21
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting
5:06pm
6-K
CLLS
Cellectis
24 May 21
Current report (foreign)
4:34pm
6-K
CLLS
Cellectis
19 May 21
Current report (foreign)
5:09pm
6-K
CLLS
Cellectis
11 May 21
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
4:31pm
6-K
CLLS
Cellectis
6 May 21
Current report (foreign)
4:39pm
6-K
CLLS
Cellectis
6 May 21
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
4:34pm
6-K
CLLS
Cellectis
27 Apr 21
Current report (foreign)
6:37am
6-K
CLLS
Cellectis
26 Apr 21
Current report (foreign)
4:42pm
6-K
CLLS
Cellectis
9 Apr 21
Cellectis Completes Sale of $47 million through its ATM Program
6:17am
6-K
CLLS
Cellectis
29 Mar 21
Current report (foreign)
4:55pm
6-K
CLLS
Cellectis
29 Mar 21
Current report (foreign)
4:38pm
424B5
CLLS
Cellectis
29 Mar 21
Prospectus supplement for primary offering
4:35pm
S-8 POS
CLLS
Cellectis
4 Mar 21
Registration of securities for employees (post-effective amendment)
5:13pm
20-F
2020 FY
CLLS
Cellectis
Annual report (foreign)
4 Mar 21
4:51pm
6-K
CLLS
Cellectis
4 Mar 21
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
4:48pm
6-K
CLLS
Cellectis
19 Feb 21
Calyxt Announces Dr. Yves Ribeill Appointed As Executive Chair Replacing
5:17pm
SC 13G/A
CLLS
Cellectis
16 Feb 21
Cellectis / Capital International Investors ownership change
3:58pm